Showcasing BactEradiX at BIO-Europe

Showcasing BactEradiX at BIO-Europe: New Opportunities for Partnership and Impact

3rd– 5th November 2025

Andrea Tortori, representing Bioridis as a partner in the BactEradiX project, participated in Bio Europe, held in Vienna from November 3rd to 5th, 2025, the leading business-to-business conference for the biotechnology and pharma sectors. The event brought together thousands of life science professionals from across the world, providing unique opportunities for networking and partnership development. Andrea’s presence at Bio Europe allowed BactEradiX to share its project objectives with a diverse range of potential stakeholders and industry leaders. The conference offered an invaluable platform to explore new avenues for future collaboration, positioning BactEradiX at the forefront of innovative research and fostering connections that will contribute to the project’s impact.


BactEradiX’s contribution to European Researchers’ Night

Meetings

26th September 2025

Our BactEradiX partners UNIBO and UNIPR, took part in the European Researchers’ Night in Bologna on 26 September, inviting researchers of all ages to explore the fascinating world of bacteria. Through engaging and simple activities, BactEradiX researchers captivated both young and old, explaining the complex world of microbes in an accessible way.

They also presented how the BactEradiX project aims to defeat drug-resistant bacteria, offering hope for innovative solutions to antimicrobial resistance. The event was a wonderful opportunity to inspire curiosity and raise awareness of cutting-edge research impacting our health and future.


UNIPG and BIORIDIS at 53° Congresso della Società Italiana di Microbiologia

UNIPG and BIORIDIS present novel MRSA biofilm model at 53° Congresso della Società Italiana di Microbiologia

19th – 22nd September 2025

BactEradiX teams UNIPG and BIORIDIS recently presented a poster titled “Development of an in vitro model of DNase-resistant methicillin-resistant Staphylococcus aureus (MRSA) biofilm reveals Z-DNA enrichment” at the 53rd Congresso della Società Italiana di Microbiologia, held from September 19 to 22, 2025, in the beautiful setting of the University of Catania. This research advances understanding of MRSA biofilm resistance mechanisms, contributing to the project’s goal of developing innovative antimicrobial nanomaterials targeting biofilm-associated infections.


BactEradiX partner Bengt Fadeel attends ChinaNano 2025 in Beijing

Meetings

30th August – 1st September 2025

BactEradiX partner, Bengt Fadeel, had recently the privilege to attend the ChinaNano 2025 meeting held in Beijing, where he delivered a keynote lecture. On this occasion, his host, Prof. Yuliang Zhao, presented Bengt with a commemorative plaque. During his visit, Bengt also gave a seminar at the National Center for Nanoscience and Technology (NCNST), Chinese Academy of Sciences (CAS), in Beijing.

This event represented a valuable opportunity for BactEradiX to foster scientific exchange and strengthen collaboration in the field of nanoscience and technology.


Prof. Cerulli presents BactEradiX project at ASSA IOSSMA 2025 in Bali

Meetings

26th – 30th August 2025

Professor Cerulli, representing the IRTAL team, recently presented the BactEradiX project during the 13th ASEAN Society for Sports Medicine and Arthroscopy (ASSA) Combined Meeting with the 5th Congress and the 13th Annual Meeting of the Indonesian Orthopaedic Society for Sports Medicine and Arthroscopy (IOSSMA), held in Bali, Indonesia. Prof. Cerulli was a speaker in a session focused on post-operative infections. The contribution of the BactEradiX project to this field has been acknowledged for its innovative approach in developing advanced nanomaterials to combat antimicrobial resistance and chronic infections. A brief video of the presentation is available for viewing.


Antimicrobic resistance (AMR) conference

Meetings

BactEradiX coordinator Paolo Blasi attended the Antimicrobial Resistance event organized by SIMeF https://www.simef.it/ and SIF https://www.sifweb.org in Milan.

Professor Blasi talked about the role of Public Engagement (PE) and how Citizen Science can help address antimicrobial resistance.


BactEradiX podcast episode is out!

Meetings

We’re excited to share the episode of Radio 24 podcast, featuring insights on the BactEradiX project – its vision, goals, and how it aims to make a real impact in the field of antimicrobial resistance
In this episode, the Coordinator Paolo Blasi discusses:
🔹 The challenges the project is addressing
🔹 The innovative solutions developed by the consortium
🔹 The value of European collaboration in driving research and innovation
The podcast episode is available here.


BactEradiX at AMSDAF public conference

Meetings

Our partner IRTAL attended a public conference on 30 May 2025, organized by AMSDAF (Ascoli and Fermo Medical Sports Association) and sponsored by the Municipality, aimed at engaging civil society on key health topics.
During the session, Prof. Cerulli presented the BactEradiX project and its objectives: pioneering transformative nanotechnology solutions to tackle chronic infections and antimicrobial resistance by eradicating biofilms and overcoming drug-resistant pathogens with biocompatible, sustainable approaches. His presentation fostered meaningful dialogue with citizens and community stakeholders, highlighting the importance of collaboration between researchers and the public.


Kick Off Meeting Bologna 2025

Successful Kick-Off Meeting of the BactEradiX Project

The Kick-Off Meeting of the BactEradiX Project took place in Bologna on January 16-17, marking a highly productive and goal-oriented start to this ambitious initiative. The event brought together all project partners, fostering valuable discussions and strategic planning.

We were honored to have the participation of Project Officer Barbara Gerratana, who joined us online to share her insights and provide essential guidance for the project’s next steps.

Funded by the European Innovation Council (EIC), BactEradiX represents a significant advancement in the fight against antimicrobial resistance, a growing global health challenge.